[go: up one dir, main page]

LT2968225T - Neosaksitoksino derinio kompozicijos, skirtos prolonguotai vietinei anestezijai - Google Patents

Neosaksitoksino derinio kompozicijos, skirtos prolonguotai vietinei anestezijai

Info

Publication number
LT2968225T
LT2968225T LTEP14719486.4T LT14719486T LT2968225T LT 2968225 T LT2968225 T LT 2968225T LT 14719486 T LT14719486 T LT 14719486T LT 2968225 T LT2968225 T LT 2968225T
Authority
LT
Lithuania
Prior art keywords
local anesthesia
combination formulations
prolonged local
neosaxitoxin
neosaxitoxin combination
Prior art date
Application number
LTEP14719486.4T
Other languages
English (en)
Inventor
Charles Berde
Daniel S. Kohane
Original Assignee
The Children`S Medical Center Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50549480&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LT2968225(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by The Children`S Medical Center Corporation filed Critical The Children`S Medical Center Corporation
Publication of LT2968225T publication Critical patent/LT2968225T/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Rheumatology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicinal Preparation (AREA)
LTEP14719486.4T 2013-03-15 2014-03-17 Neosaksitoksino derinio kompozicijos, skirtos prolonguotai vietinei anestezijai LT2968225T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361789054P 2013-03-15 2013-03-15
PCT/US2014/030372 WO2014145580A1 (en) 2013-03-15 2014-03-17 Neosaxitoxin combination formulations for prolonged local anesthesia

Publications (1)

Publication Number Publication Date
LT2968225T true LT2968225T (lt) 2019-04-25

Family

ID=50549480

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP14719486.4T LT2968225T (lt) 2013-03-15 2014-03-17 Neosaksitoksino derinio kompozicijos, skirtos prolonguotai vietinei anestezijai

Country Status (25)

Country Link
US (4) US10314833B2 (lt)
EP (2) EP3492075B1 (lt)
JP (1) JP6313420B2 (lt)
KR (4) KR20220132666A (lt)
CN (1) CN105142625B (lt)
AU (2) AU2014232881B2 (lt)
CA (2) CA2906851C (lt)
CL (1) CL2015002534A1 (lt)
CY (1) CY1121606T1 (lt)
DK (1) DK2968225T3 (lt)
ES (2) ES2727292T3 (lt)
HR (1) HRP20190419T1 (lt)
HU (1) HUE042711T2 (lt)
IL (1) IL241346B (lt)
LT (1) LT2968225T (lt)
MX (1) MX390159B (lt)
NZ (1) NZ710890A (lt)
PE (1) PE20160011A1 (lt)
PL (2) PL2968225T3 (lt)
PT (1) PT2968225T (lt)
RS (1) RS58750B1 (lt)
RU (2) RU2015143665A (lt)
SI (1) SI2968225T1 (lt)
TR (1) TR201903411T4 (lt)
WO (1) WO2014145580A1 (lt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014232881B2 (en) * 2013-03-15 2017-04-27 The Children's Medical Center Corporation Neosaxitoxin combination formulations for prolonged local anesthesia
WO2016100209A1 (en) 2014-12-15 2016-06-23 The Children's Medical Center Corporation Non-toxic topical anesthetic ophthalmic compositions
ES3030273T3 (en) 2015-10-08 2025-06-27 Childrens Medical Ct Corp Compositions and compositions for use in on-demand high-efficiency triggerable anesthesia
US10117847B2 (en) 2015-12-04 2018-11-06 Ventis Pharma Extended duration local anesthetic formulation
US10791651B2 (en) 2016-05-31 2020-09-29 Carbice Corporation Carbon nanotube-based thermal interface materials and methods of making and using thereof
US20210275678A1 (en) * 2017-12-01 2021-09-09 The Children's Medical Center Corporation Covalent anesthetic-polymer conjugates for prolonged local anesthesia
RU2701571C1 (ru) * 2019-02-13 2019-09-30 Федеральное государственное бюджетное образовательное учреждение высшего образования "Казанский Государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ профилактики болевого синдрома после вмешательств на коленном суставе
US20230052318A1 (en) * 2020-01-06 2023-02-16 Pacira Pharmaceuticals, Inc. Treatment of pain associated with cesarean section surgery with sustained-release liposomal anesthetic compositions
US20230130180A1 (en) 2020-01-10 2023-04-27 Pacira Pharmaceuticals, Inc. Treatment of pain by administration of sustained-release liposomal anesthetic compositions
EP4087554A4 (en) 2020-01-10 2024-01-17 Pacira Pharmaceuticals, Inc. TREATMENT OF PAIN BY SUBARACHNOID ADMINISTRATION OF SUSTAINED-RELEASE LIPOSOMAL ANESTHETICAL COMPOSITIONS
CN116997338A (zh) 2021-01-11 2023-11-03 帕西拉制药股份有限公司 用缓释脂质体麻醉剂组合物治疗髋部疼痛
WO2022197899A2 (en) 2021-03-19 2022-09-22 Pacira Pharmaceuticals, Inc. Treatment of pain in pediatric patients by administration of sustained-release liposomal anesthetic compositions
US11918565B1 (en) 2022-11-03 2024-03-05 Pacira Pharmaceuticals, Inc. Treatment of post-operative pain via sciatic nerve block with sustained-release liposomal anesthetic compositions
US12226610B2 (en) 2022-11-03 2025-02-18 Pacira Pharmaceuticals, Inc. Treatment of pain associated with total knee arthroplasty with sustained-release liposomal anesthetic compositions
EP4648760A1 (en) * 2023-01-13 2025-11-19 Smilanich, Michael D. Composition for local anesthesia and uses thereof
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3004894A (en) 1959-04-07 1961-10-17 Upjohn Co Therapeutic composition comprising tetracycline and a dioxolane
US3328259A (en) 1964-01-08 1967-06-27 Parachem Corp Dressing for a wound containing a hemostatic agent and method of treating a wound
US3374144A (en) 1965-10-07 1968-03-19 Miles Lab Ophthalmic composition
SE391286B (sv) 1971-01-26 1977-02-14 Astra Pharma Prod Forfarande for framstellning av en lokalanestetiskt verksam injektionslosning med forlengd varaktighet av verkan
US3957996A (en) 1971-12-08 1976-05-18 Astra Pharmaceutical Products, Inc. Pharmaceutical local anesthetic compositions
US3966934A (en) 1971-12-08 1976-06-29 Astra Pharmaceutical Products, Inc. Synergistic local anesthetic compositions
US4022899A (en) 1973-06-12 1977-05-10 Astra Pharmaceutical Products, Inc. Synergistic local anesthetic compositions
US4029793A (en) 1973-06-12 1977-06-14 Astra Pharmaceutical Products, Inc. Synergistic local anesthetic compositions
US4001413A (en) 1973-06-12 1977-01-04 Astra Pharmaceutical Products, Inc. Pharmaceutical local anesthetic composition employing saxitoxin
US4029794A (en) 1973-06-12 1977-06-14 Astra Pharmaceutical Products, Inc. Pharmaceutical local anesthetic composition
CA1165240A (en) 1980-07-09 1984-04-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions
US4313958A (en) 1980-10-24 1982-02-02 The Procter & Gamble Company Method of producing analgesia
US4401663A (en) 1981-06-30 1983-08-30 The Procter & Gamble Company Novel sulfonamide derivatives
US4460602A (en) 1981-06-30 1984-07-17 The Procter & Gamble Company Urea derivatives
US4443473A (en) 1981-06-30 1984-04-17 The Procter & Gamble Company Carbamate derivatives
US4537776A (en) 1983-06-21 1985-08-27 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl) pyrrolidone
US4564633A (en) 1983-07-14 1986-01-14 The Procter & Gamble Company Compositions and methods useful for producing analgesia
US4544668A (en) 1983-07-14 1985-10-01 The Procter & Gamble Company Compounds and compositions useful for producing analgesia
US4544669A (en) 1983-07-14 1985-10-01 The Procter & Gamble Company Compounds and compositions useful for producing analgesia
US4493848A (en) 1983-07-14 1985-01-15 The Procter & Gamble Company Compositions and methods useful for producing analgesia
US4605670A (en) 1984-02-01 1986-08-12 Nitto Electric Industrial Co., Ltd. Method for percutaneously administering metoclopramide
CA1274508A (en) 1984-05-31 1990-09-25 Imre Szilagyi Primycin components and process for the separation of the antibiotic complex
US4654323A (en) 1984-11-13 1987-03-31 Bar Ilan University Method and composition for the therapeutic and prophylactic treatment of trauma to the skin
US5013759A (en) 1985-06-10 1991-05-07 The Procter & Gamble Company Compounds and compositions having anti-inflammatory and analgesic activity
US4863970A (en) 1986-11-14 1989-09-05 Theratech, Inc. Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols
US5006342A (en) 1986-12-22 1991-04-09 Cygnus Corporation Resilient transdermal drug delivery device
US5045565A (en) 1987-03-09 1991-09-03 The Procter & Gamble Company Novel compounds, pharmaceutical compositions, and methods for treating inflammation and pain
US5099030A (en) 1987-03-09 1992-03-24 The Procter & Gamble Company Novel compounds, pharmaceutical compositions, and methods for treating inflammation and pain
US4820720A (en) 1987-08-24 1989-04-11 Alza Corporation Transdermal drug composition with dual permeation enhancers
US5871472A (en) 1987-11-17 1999-02-16 Brown University Research Foundation Planting devices for the focal release of neuroinhibitory compounds
US5134166A (en) 1988-12-02 1992-07-28 Genderm Corporation Method for treating nasal disorders and headaches
US5008289A (en) 1988-12-02 1991-04-16 Galenpharma, Inc. Composition for treating nasal disorders and headaches
US4997853A (en) 1988-12-02 1991-03-05 Galenpharma, Inc. Method and compositions utilizing capsaicin as an external analgesic
US4973468A (en) 1989-03-22 1990-11-27 Cygnus Research Corporation Skin permeation enhancer compositions
WO1993011798A1 (en) 1991-12-16 1993-06-24 Alza Corporation Improved formulations with hydrophobic permeation enhancers
US5700485A (en) 1992-09-10 1997-12-23 Children's Medical Center Corporation Prolonged nerve blockade by the combination of local anesthetic and glucocorticoid
DE69331387T2 (de) 1992-09-10 2002-08-22 Childrens Medical Center Biodegradierbare polymeren matrizen mit verzoegerter freisetzung von lokalanaesthetika
US5576016A (en) 1993-05-18 1996-11-19 Pharmos Corporation Solid fat nanoemulsions as drug delivery vehicles
RU2168331C2 (ru) 1994-03-17 2001-06-10 Наннинь Мапле Лиаф Фармацевтикал Ко., Лтд. Применение соединений аминогидрогенизированного хиназолина и их производных для лечения наркотической зависимости
ATE267587T1 (de) 1995-06-09 2004-06-15 Euro Celtique Sa Formulierungen und verfahren für eine verlängerte lokalanästhesie
US5858397A (en) 1995-10-11 1999-01-12 University Of British Columbia Liposomal formulations of mitoxantrone
WO1998043619A2 (en) 1997-04-02 1998-10-08 The Regents Of The University Of California Method of local anesthesia
AU7389098A (en) 1997-05-16 1998-12-08 Brigham And Women's Hospital Local anesthetic formulations
US7016870B1 (en) 1997-12-02 2006-03-21 Financial Engines Identifying a recommended portfolio of financial products for an investor based upon financial products that are available to the investor
WO2001041550A2 (en) 1999-10-22 2001-06-14 Transdermatech, Inc. Topical anesthetic formulation
US6673363B2 (en) 1999-12-16 2004-01-06 Dermatrends, Inc. Transdermal and topical administration of local anesthetic agents using basic enhancers
US6455066B1 (en) 2000-03-10 2002-09-24 Epicept Corporation Intradermal-penetration agents for topical local anesthetic administration
CN1284536C (zh) 2000-09-18 2006-11-15 威克斯医药有限公司 河豚毒素或蛤蚌毒素及其类似物在制备用于全身镇痛的镇痛药中的应用
CN1236773C (zh) 2000-11-22 2006-01-18 南宁枫叶药业有限公司 用于镇痛、麻醉或治疗药物依赖性的制剂
WO2002058670A1 (en) * 2001-01-25 2002-08-01 Euroceltique S.A. Local anesthetic, and method of use
CN1382443A (zh) 2001-04-25 2002-12-04 威克斯医疗仪器有限公司 钠离子通道阻断剂在制备用于局部神经麻醉或镇痛的药物中的应用
ES2401570T3 (es) * 2001-11-15 2013-04-22 Phytotox Limited Composiciones farmacéuticas que contienen 3,4-propinoperhidropurinas y usos de las mismas para bloquear la transmisión neuronal
US20050202093A1 (en) 2002-12-02 2005-09-15 Kohane Daniel S. Prolonged suppression of electrical activity in excitable tissues
US20040172354A1 (en) 2003-02-13 2004-09-02 Charnley James Allen Calculator for illustrating investment performance for irregular time periods
WO2005079157A2 (en) 2004-02-19 2005-09-01 Dmitry Gorbatovsky Portfolio optimization
US20050214325A1 (en) 2004-03-26 2005-09-29 Vvii Newco 2003, Inc. Compositions and methods to increase the effect of a neurotoxin treatment
CN101123967A (zh) 2004-05-07 2008-02-13 菲特托克斯有限公司 藻毒素的经皮给药
CN100367966C (zh) 2004-09-28 2008-02-13 黄致强 河鲀毒素油相制剂的制备方法
WO2006091719A2 (en) 2005-02-23 2006-08-31 Sontra Medical Corporation Compositions and methods enhancing transdermal delivery of drugs and biologics
AU2007322033B2 (en) 2006-11-20 2013-07-11 President And Fellows Of Harvard College Methods, compositions, and kits for treating pain and pruritis
WO2009143175A2 (en) 2008-05-19 2009-11-26 Children's Medical Center Corporation Sensory-specific local anesthesia and prolonged duration local anesthesia
US8658699B2 (en) 2008-05-19 2014-02-25 Massachusetts Institute Of Technology Chemical permeation enhancers enhance nerve blockade by toxins
EP2344133B1 (en) 2008-10-07 2019-06-26 Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. A composition of matter comprising liposomes embedded in a polymeric matrix and methods of using same
CL2009000722A1 (es) 2009-03-24 2009-06-19 Proteus Sa Metodo de obtención y producción masiva de una especie de cianobacteria aislada productora de ficotoxinas paralizantes, utilizando un medio de cultivo mla suplementado con arginina, metionina y ácido alantoico.
CL2009000723A1 (es) 2009-03-24 2009-06-19 Proteus Sa Metodo de purificacion industrial de ficotoxinas biologicamente activas que comprende proporcionar una cantidad adecuada de una fuente de ficotoxinas como por ejemplo el cultivo de un clon de cianobacterias.
US20120034296A1 (en) 2009-04-08 2012-02-09 Massachusetts Institute Of Technology Prolonged duration local anesthesia with minimal toxicity
CN102459273A (zh) 2009-05-07 2012-05-16 里兰斯坦福初级大学理事会 用于研究、成像以及治疗疼痛的方法和组合物
JP6112867B2 (ja) * 2010-02-10 2017-04-12 ファイトトックス リミテッドＰｈｙｔｏｔｏｘ Ｌｉｍｉｔｅｄ サキシトキシン誘導体での触覚の喪失の処置
AU2014232881B2 (en) * 2013-03-15 2017-04-27 The Children's Medical Center Corporation Neosaxitoxin combination formulations for prolonged local anesthesia

Also Published As

Publication number Publication date
HRP20190419T1 (hr) 2019-05-03
DK2968225T3 (da) 2019-05-27
CA2906851A1 (en) 2014-09-18
WO2014145580A1 (en) 2014-09-18
JP6313420B2 (ja) 2018-04-18
TR201903411T4 (tr) 2019-04-22
HK1218384A1 (zh) 2017-02-17
MX390159B (es) 2025-03-20
US10881647B2 (en) 2021-01-05
US8975268B2 (en) 2015-03-10
CA3018668A1 (en) 2014-09-18
AU2017202343A1 (en) 2017-04-27
PL2968225T3 (pl) 2019-08-30
PT2968225T (pt) 2019-04-02
ES2727292T3 (es) 2019-10-15
RS58750B1 (sr) 2019-06-28
SI2968225T1 (sl) 2019-05-31
PL3492075T3 (pl) 2024-04-22
JP2016514704A (ja) 2016-05-23
US20140329861A1 (en) 2014-11-06
AU2017202343B2 (en) 2019-02-07
CA2906851C (en) 2019-05-07
MX2015012879A (es) 2016-06-24
HUE042711T2 (hu) 2019-07-29
KR20150131330A (ko) 2015-11-24
KR20220132666A (ko) 2022-09-30
BR112015021380A2 (pt) 2018-05-08
IL241346B (en) 2018-07-31
EP3492075A1 (en) 2019-06-05
CA3018668C (en) 2021-04-13
US8975281B2 (en) 2015-03-10
US20190247377A1 (en) 2019-08-15
AU2014232881B2 (en) 2017-04-27
RU2015143665A (ru) 2017-04-27
AU2014232881A1 (en) 2015-08-27
KR20210062693A (ko) 2021-05-31
NZ710890A (en) 2016-11-25
IL241346A0 (en) 2015-11-30
KR20240042210A (ko) 2024-04-01
EP2968225B1 (en) 2019-02-20
KR102787826B1 (ko) 2025-03-31
ES2972603T3 (es) 2024-06-13
US20140329841A1 (en) 2014-11-06
CN105142625A (zh) 2015-12-09
US20140288103A1 (en) 2014-09-25
CY1121606T1 (el) 2020-05-29
RU2673081C1 (ru) 2018-11-22
US10314833B2 (en) 2019-06-11
PE20160011A1 (es) 2016-02-10
EP2968225A1 (en) 2016-01-20
EP3492075B1 (en) 2023-12-13
CL2015002534A1 (es) 2016-09-16
CN105142625B (zh) 2019-09-06

Similar Documents

Publication Publication Date Title
IL241346A0 (en) Neosaxitoxin combination formulations for prolonged local anesthesia
GB201319791D0 (en) Formulations
IL240846A0 (en) drug combination
IL243080B (en) Alkhush helmet
AU353438S (en) Bed rail
GB201319792D0 (en) Formulations
EP3017727A4 (en) CUSHION FOR SHARED SLEEP
EP2910227A4 (en) REMOVABLE BED
IL245420A0 (en) New formulations
IL242493A0 (en) Pharmaceutical formulations relieve radioactivity
SG11201507957VA (en) Stabilized vitamin d formulations
GB2517922B (en) Train set
PL2821061T3 (pl) Nowe preparaty do inhalacji
GB2583319B (en) Integrated nanospray system
IL246393A0 (en) Prodrug compounds
GB2516706B (en) Railway points
PH32013000147S1 (en) DETACHABLE BED (Eurotop)
PH22013000360U1 (en) Detachable bed
GB201320093D0 (en) Tram
AU352341S (en) Fitting for furniture
AU352342S (en) Fitting for furniture
AU352351S (en) Locomotive
AU352352S (en) Locomotive
GB201313076D0 (en) Train
GB201318903D0 (en) Hyrdolic cot rail